Management of Acute Asthma Exacerbation
Immediately administer high-dose inhaled beta-2 agonists (salbutamol 5 mg or terbutaline 10 mg nebulized), oxygen to maintain saturation >90%, and systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) as first-line treatment for all acute asthma exacerbations. 1
Initial Assessment and Severity Classification
Rapidly assess severity using objective measurements—never rely on symptoms alone, as underestimation kills patients 1:
Severe Asthma Features:
- Cannot complete sentences in one breath
- Respiratory rate >25 breaths/min
- Heart rate >110 beats/min
- Peak expiratory flow (PEF) <50% predicted or personal best 1
Life-Threatening Features:
- PEF <33% predicted
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, or coma
- Normal or elevated PaCO2 (5-6 kPa or higher) in a breathless patient
- Severe hypoxia (PaO2 <8 kPa) despite oxygen 1
Immediate Treatment Protocol
First-Line Therapy (Start Simultaneously):
Oxygen: 40-60% via mask or nasal cannula to maintain SpO2 >90% (>95% in pregnancy or cardiac disease) 1, 2
Nebulized Beta-2 Agonist: Salbutamol 5 mg or terbutaline 10 mg, oxygen-driven nebulizer. Can repeat every 20-30 minutes for first hour 1, 2
- Alternative if no nebulizer: 2 puffs via large-volume spacer, repeat 10-20 times 1
Systemic Corticosteroids: Prednisolone 30-60 mg PO OR hydrocortisone 200 mg IV (or both) 1
- Critical point: Underuse of corticosteroids is a major preventable cause of asthma deaths 1
Additional Therapy for Life-Threatening or Severe Cases:
Ipratropium Bromide: Add 0.5 mg to nebulizer with beta-agonist, repeat 6-hourly 1
IV Bronchodilators (if life-threatening features present):
- Aminophylline 250 mg over 20 minutes OR
- Salbutamol or terbutaline 250 µg over 10 minutes
- Caution: Do NOT give bolus aminophylline if patient already on oral theophyllines 1
Reassessment at 15-30 Minutes
If improving:
- Continue oxygen
- Continue prednisolone 1-2 mg/kg daily (max 40 mg)
- Nebulized beta-agonist 4-hourly 1
If NOT improving:
- Continue oxygen and steroids
- Increase nebulized beta-agonist frequency up to every 30 minutes
- Add ipratropium if not already given
- Consider hospital admission 1
Hospital Admission Criteria
Admit immediately if:
- Any life-threatening features present
- PEF remains <33% after initial treatment
- Features of severe asthma persist 15-30 minutes after initial treatment 1
Lower threshold for admission if:
- Attack occurs afternoon/evening
- Recent nocturnal symptoms or hospital admission
- Previous severe attacks, especially rapid onset
- Patient unable to assess own severity
- Concerning social circumstances 1
ICU Transfer Indications
Transfer to ICU with physician prepared to intubate if:
- Deteriorating PEF despite treatment
- Worsening exhaustion, feeble respirations
- Persistent or worsening hypoxia/hypercapnia
- Coma, respiratory arrest, confusion, or drowsiness 1
Hospital Investigations
- Arterial blood gas: Mandatory for all hospital admissions; normal/high PaCO2 indicates life-threatening attack 1
- Chest X-ray: Only if suspected pneumothorax, pneumonia, consolidation, or pulmonary edema 1
- Pulse oximetry: Continuous monitoring until clear response 2
- Electrolytes, blood count in selected cases 1
Discharge Criteria
Patient must meet ALL criteria:
- On discharge medication for 24 hours
- Inhaler technique checked and recorded
- PEF >75% predicted or personal best
- PEF diurnal variability <25%
- Prescribed oral steroids AND inhaled steroids plus bronchodilators
- Own PEF meter with self-management plan
- GP follow-up arranged within 1 week
- Clinic follow-up within 4 weeks 1
Critical Pitfalls to Avoid
- Never underestimate severity—objective measurements (PEF, vital signs) trump clinical impression 1
- Never delay corticosteroids—this is the most common preventable cause of asthma death 1
- Never discharge without ensuring 24-hour stability on treatment 1
- Never give aminophylline bolus to patients on oral theophyllines 1
- Never treat with SABA alone long-term—all patients need ICS-containing therapy 3, 4
The evidence consistently demonstrates that rapid, aggressive treatment with the triad of oxygen, beta-agonists, and systemic corticosteroids forms the cornerstone of acute asthma management, with ipratropium and IV bronchodilators reserved for severe/life-threatening cases 1, 2.